| Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival GE Chung, JH Lee, HY Kim, SY Hwang, JS Kim, JW Chung, JH Yoon, ... Radiology 258 (2), 627-634, 2011 | 367 | 2011 |
| Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma JW Park, YH Koh, HB Kim, HY Kim, S An, JI Choi, SM Woo, BH Nam Journal of hepatology 56 (6), 1336-1342, 2012 | 199 | 2012 |
| Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: the phase III STAH trial JW Park, YJ Kim, SH Bae, SW Paik, YJ Lee, HY Kim, HC Lee, SY Han, ... Journal of hepatology 70 (4), 684-691, 2019 | 180 | 2019 |
| Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma JH Lee, GE Chung, SJ Yu, SY Hwang, JS Kim, HY Kim, JH Yoon, HS Lee, ... Journal of clinical gastroenterology 45 (1), 69-75, 2011 | 160 | 2011 |
| Visceral obesity predicts significant fibrosis in patients with nonalcoholic fatty liver disease SJ Yu, W Kim, D Kim, JH Yoon, K Lee, JH Kim, EJ Cho, JH Lee, HY Kim, ... Medicine 94 (48), e2159, 2015 | 146 | 2015 |
| Serum tumor markers provide refined prognostication in selecting liver transplantation candidate for hepatocellular carcinoma patients beyond the Milan criteria JH Lee, Y Cho, HY Kim, EJ Cho, DH Lee, SJ Yu, JW Lee, NJ Yi, KW Lee, ... Annals of surgery 263 (5), 842-850, 2016 | 140 | 2016 |
| A genome-wide association study identified new variants associated with the risk of chronic hepatitis B YJ Kim, HY Kim, JH Lee, SJ Yu, JH Yoon, HS Lee, CY Kim, JY Cheong, ... Human molecular genetics 22 (20), 4233-4238, 2013 | 110 | 2013 |
| 2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma JW Park, JS Lee, KS Suh, JW Chung, J Seong, DY Kim, JH Kim, HJ Kim, ... Gut and liver 13 (3), 227-299, 2019 | 101 | 2019 |
| An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B HY Kim, P Lampertico, JY Nam, HC Lee, SU Kim, DH Sinn, YS Seo, ... Journal of Hepatology 76 (2), 311-318, 2022 | 97 | 2022 |
| Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects Y Yun, HN Kim, E Lee, S Ryu, Y Chang, H Shin, HL Kim, TH Kim, K Yoo, ... PloS one 14 (3), e0213692, 2019 | 90 | 2019 |
| Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices HY Kim, YH So, W Kim, DW Ahn, YJ Jung, H Woo, D Kim, MY Kim, ... Journal of hepatology 70 (3), 412-422, 2019 | 86 | 2019 |
| Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma HY Kim, JW Park, J Joo, SJ Jung, S An, SM Woo, HB Kim, YH Koh, ... Journal of gastroenterology and hepatology 27 (6), 1051-1056, 2012 | 75 | 2012 |
| The role of spleen stiffness in determining the severity and bleeding risk of esophageal varices in cirrhotic patients HY Kim, EH Jin, W Kim, JY Lee, H Woo, S Oh, JY Seo, HS Oh, KH Chung, ... Medicine 94 (24), e1031, 2015 | 70 | 2015 |
| Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and future HY Kim, JW Park Liver cancer 3 (1), 9-17, 2014 | 65 | 2014 |
| Recent advances in nonalcoholic fatty liver disease metabolomics HY Kim Clinical and molecular hepatology 27 (4), 553, 2021 | 61 | 2021 |
| Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir‐based combination therapy M Lee, S Oh, HJ Lee, TS Yeum, JH Lee, SJ Yu, HY Kim, JH Yoon, HS Lee, ... Journal of Viral Hepatitis 21 (12), 873-881, 2014 | 54 | 2014 |
| Worse outcome of sorafenib therapy associated with ascites and C hild‐P ugh score in advanced hepatocellular carcinoma HY Kim, JW Park, J Joo, H Kim, SM Woo, WJ Lee, CM Kim Journal of gastroenterology and hepatology 28 (11), 1756-1761, 2013 | 52 | 2013 |
| Chemotherapy-related reactivation of hepatitis B infection: updates in 2013 HY Kim, W Kim World Journal of Gastroenterology: WJG 20 (40), 14581, 2014 | 50 | 2014 |
| Characterization of acute‐on‐chronic liver failure and prediction of mortality in Asian patients with active alcoholism HY Kim, Y Chang, JY Park, H Ahn, H Cho, SJ Han, S Oh, D Kim, YJ Jung, ... Journal of gastroenterology and hepatology 31 (2), 427-433, 2016 | 40 | 2016 |
| Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatments HY Kim, JW Park, BH Nam, HK Kim, JI Choi, TH Kim, HB Kim, CM Kim Journal of gastroenterology and hepatology 26 (11), 1612-1618, 2011 | 39 | 2011 |